SARS-CoV-2 infection (COVID-19) in children
Paediatria Croatica
; 64(2):94-100, 2020.
Article
in Croatian
| EMBASE | ID: covidwho-1884766
ABSTRACT
Since the outbreak in December 2019, the SARS-CoV-2 pandemic virus has been a major public health problem in all countries of the world. The virus is transmitted by inhalation of respiratory droplets from the patient or asymptomatic carrier and is highly contagious. The clinical disease in children is similar to any acute respiratory infection with predominant upper respiratory symptoms, but occasionally can progress to pneumonia with acute respiratory distress syndrome and multiorgan failure. The disease is milder in children than in adults, with low mortality, and it appears that infants and young children have a somewhat more severe clinical course. Diagnosis is made by detecting the virus from respiratory samples (mainly nasopharyngeal and oropharyngeal swabs) using polymerase chain reaction. Treatment is usually symptomatic, and in severe and critical forms, the use of one of the antiviral drugs (lopinavir-ritonavir, remdesivir, hydroxychloroquine) may be considered
adult; adult respiratory distress syndrome; article; asymptomatic carrier; child; controlled study; coronavirus disease 2019; gene amplification; human; infant; inhalation; mortality; multiple organ failure; nonhuman; oropharyngeal swab; pandemic; pneumonia; polymerase chain reaction; public health problem; respiratory droplets and aerosols; respiratory tract infection; Severe acute respiratory syndrome coronavirus 2; antivirus agent; hydroxychloroquine; lopinavir plus ritonavir; remdesivir
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Croatian
Journal:
Paediatria Croatica
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS